Two Different Blocks for Postoperative Analgesia in Patients Undergoing Unilateral Total Knee Arthroplasty

Pain, Postoperative Clinical Trial

Official title:

Comparison of the Effects of Femoral Nerve Block and Adductor Canal Block on Postoperative Analgesia in Patients Undergoing Unilateral Total Knee Arthroplasty

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04286035
• Other study ID #: SK01
• Status: Completed
• Phase: Phase 4
• Start date: April 2, 2019
• Est. completion date: October 1, 2019

Study information

• Verified date: March 2020
• Source: Sisli Hamidiye Etfal Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The frequency of femoral nerve block and adductor canal block for analgesia after TKA(total knee arthroplasty) increases with the use of ultrasonography in regional anesthesia. In this study, we aimed to compare the effects of femoral nerve block and adductor canal block on postoperative analgesia in patients undergoing unilateral knee arthroplasty.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 70
• Est. completion date: October 1, 2019
• Est. primary completion date: September 29, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 55 Years and older

Eligibility

Inclusion Criteria:

• ASA(American Society of Anesthesiologists) Classification I-II

• Age: <55 years

• Unilateral total knee arthroplasty

Exclusion Criteria:

• Does not approve the study

• Pregnant

• Emergency

• ASA III-IV

• History of local anesthetic allergy

• Infection in the block area

• Coagulation disorder

• Morbid obesity (body mass index> 40 kg / m²)

• Severe organ failure

• Previous neurological deficit

• Psychiatric disease

• History of chronic pain

Related Conditions & MeSH terms

• Anesthesia, Regional
• Knee Replacement, Total
• Pain, Postoperative

Intervention

Drug:
• Bupivacaine Injection
Femoral nerve block with 20 ml %0.375 bupivacaine
• Bupivacaine Injection
Adductor canal block with 20 ml %0.375 bupivacaine

Locations

Country	Name	City	State
Turkey	SBÜ Sisli Hamidiye Etfal Egitim ve Arastirma Hastanesi	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Sisli Hamidiye Etfal Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Tramadol consumption	Postoperative tramadol consumption with patient controlled analgesia	24 hours after operation
Primary	VAS(visual analogue scale) score (0-10, 0 is no pain, 10 is the most severe pain)	VAS(visual analogue scale) score (0-10, 0 is no pain, 10 is the most severe pain) is less than four is adequate analgesia	24 hours after operation
Primary	Rescue analgesic requirement	If VAS(visual analogue scale) score (0-10, 0 is no pain, 10 is the most severe pain) is is four or more, paracetamol 1000 mg is administered	24 hours after operation
Secondary	Postoperative nausea and vomiting	Frequency of postoperative nausea and vomiting	24 hours after operation